Human Molecular Genetics, Vol 6, 1559-1564, Copyright © 1997 by Oxford University Press
D Brett, S Whitehouse, P Antonson, J Shipley, C Cooper and G Goodwin
The t(X;18)(p11.2;q11.2) translocation found in synovial sarcomas results
in the fusion of the SYT gene on chromosome 18 to either of two closely
related genes SSX1 and SSX2 on chromosome X. The resulting chimaeric genes
express SYT-SSX1 or SYT-SSX2 fusion proteins in which the C-terminal amino
acids of SYT are replaced by amino acids from the C-terminus of the SSX
proteins. Using green fluorescent protein fusions we demonstrate that the
SYT, SSX and the SYT-SSX proteins are nuclear proteins. We demonstrate that
whilst the SSX1 protein has a uniform nuclear distribution the SYT protein
has a speckled distribution in the cell nucleus, and this distribution is
retained with the SYT-SSX2 fusion protein. Since the SYT speckles do not
co-localise with PML- containing bodies (PODs) or spliceosomes it is
possible that they represent a novel nuclear structure. Transfection of
constructs expressing GAL4 fusion proteins demonstrate that the SYT domains
present in the SYT-SSX fusion proteins can activate transcription of a
luciferase reporter. It is proposed that the t(X;18) translocation results
in the generation of an SYT-SSX transcriptional co-activator in which the
addition of the C-terminal SSX domain to SYT provides a new interacting
domain that redirects the SYT activation domain to different target
promoters.
ARTICLES
The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies
Section of Molecular Carcinogenesis, Institute of Cancer Research, Haddow Laboratories, Sutton, Surrey, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. K. Kang, R. Schiff, L. Ko, T. Wang, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley Dual Roles for Coactivator Activator and its Counterbalancing Isoform Coactivator Modulator in Human Kidney Cell Tumorigenesis Cancer Res., October 1, 2008; 68(19): 7887 - 7896. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lubieniecka, D. R.H. de Bruijn, L. Su, A. H.A. van Dijk, S. Subramanian, M. van de Rijn, N. Poulin, A. G. van Kessel, and T. O. Nielsen Histone Deacetylase Inhibitors Reverse SS18-SSX-Mediated Polycomb Silencing of the Tumor Suppressor Early Growth Response 1 in Synovial Sarcoma Cancer Res., June 1, 2008; 68(11): 4303 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D'Arcy, W. Maruwge, B. A. Ryan, and B. Brodin The Oncoprotein SS18-SSX1 Promotes p53 Ubiquitination and Degradation by Enhancing HDM2 Stability Mol. Cancer Res., January 1, 2008; 6(1): 127 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishida, M. Miyamoto, S. Naitoh, D. Tatsuda, T. Hasegawa, T. Nemoto, H. Yokozeki, K. Nishioka, A. Matsukage, M. Ohki, et al. The SYT-SSX Fusion Protein Down-Regulates the Cell Proliferation Regulator COM1 in t(x;18) Synovial Sarcoma Mol. Cell. Biol., February 15, 2007; 27(4): 1348 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Luo, X. Xiao, D. Liu, S. Chen, M. Li, A. Xu, J. Liu, S. Gao, S. Wu, and D. He CABYR Is a Novel Cancer-Testis Antigen in Lung Cancer Clin. Cancer Res., February 15, 2007; 13(4): 1288 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R.H. de Bruijn, S. V. Allander, A. H.A. van Dijk, M. P. Willemse, J. Thijssen, J. J.M. van Groningen, P. S. Meltzer, and A. Geurts van Kessel The Synovial Sarcoma-Associated SS18-SSX2 Fusion Protein Induces Epigenetic Gene (De)Regulation Cancer Res., October 1, 2006; 66(19): 9474 - 9482. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.R.H. de Bruijn, W.J.M. Peters, S.M. Chuva de Sousa Lopes, A.H.A. van Dijk, M.P. Willemse, R. Pfundt, P. de Boer, and A. Geurts van Kessel Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression Hum. Mol. Genet., October 1, 2006; 15(19): 2936 - 2944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Perani, P. Antonson, R. Hamoudi, C. J. E. Ingram, C. S. Cooper, M. D. Garrett, and G. H. Goodwin The Proto-oncoprotein SYT Interacts with SYT-interacting Protein/Co-activator Activator (SIP/CoAA), a Human Nuclear Receptor Co-activator with Similarity to EWS and TLS/FUS Family of Proteins J. Biol. Chem., December 30, 2005; 280(52): 42863 - 42876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishida, S. Tanaka, M. Ohki, and T. Ohta Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1 Genes Cells, May 1, 2004; 9(5): 419 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Aizawa, S.-C. Hu, K. Bobb, K. Balakrishnan, G. Ince, I. Gurevich, M. Cowan, and A. Ghosh Dendrite Development Regulated by CREST, a Calcium-Regulated Transcriptional Activator Science, January 9, 2004; 303(5655): 197 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Garrett-Engele, M. L. Siegal, D. S. Manoli, B. C. Williams, H. Li, and B. S. Baker intersex, a gene required for female sexual development in Drosophila, is expressed in both sexes and functions together with doublesex to regulate terminal differentiation Development, March 12, 2003; 129(20): 4661 - 4675. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, B. Skytting, G. Nilsson, A. Gasbarri, K. Haslam, A. Bartolazzi, B. Brodin, N. Mandahl, and O. Larsson SYT-SSX Is Critical for Cyclin D1 Expression in Synovial Sarcoma Cells: A Gain of Function of the t(X;18)(p11.2;q11.2) Translocation Cancer Res., July 1, 2002; 62(13): 3861 - 3867. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kato, A. Tjernberg, W. Zhang, A. N. Krutchinsky, W. An, T. Takeuchi, Y. Ohtsuki, S. Sugano, D. R. de Bruijn, B. T. Chait, et al. SYT Associates with Human SNF/SWI Complexes and the C-terminal Region of Its Fusion Partner SSX1 Targets Histones J. Biol. Chem., February 8, 2002; 277(7): 5498 - 5505. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Chan and N. B. La Thangue p300/CBP proteins: HATs for transcriptional bridges and scaffolds J. Cell Sci., January 7, 2001; 114(13): 2363 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sahin, M. Koslowski, O. Türeci, T. Eberle, C. Zwick, B. Romeike, J.-R. Moringlane, K. Schwechheimer, W. Feiden, and M. Pfreundschuh Expression of Cancer Testis Genes in Human Brain Tumors Clin. Cancer Res., October 1, 2000; 6(10): 3916 - 3922. [Abstract] [Full Text] |
||||
![]() |
T Kasai, S Shimajiri, and H Hashimoto Detection of SYT-SSX fusion transcripts in both epithelial and spindle cell areas of biphasic synovial sarcoma using laser capture microdissection Mol. Pathol., April 1, 2000; 53(2): 107 - 110. [Abstract] [Full Text] |
||||
![]() |
N. R. dos Santos, R. Torensma, T. J. de Vries, M. W. J. Schreurs, D. R. H. de Bruijn, E. Kater-Baats, D. J. Ruiter, G. J. Adema, G. N. P. van Muijen, and A. G. van Kessel Heterogeneous Expression of the SSX Cancer/Testis Antigens in Human Melanoma Lesions and Cell Lines Cancer Res., March 1, 2000; 60(6): 1654 - 1662. [Abstract] [Full Text] |
||||
![]() |
M. G. Stacey and A. G. von Arnim A Novel Motif Mediates the Targeting of the Arabidopsis COP1 Protein to Subnuclear Foci J. Biol. Chem., September 17, 1999; 274(38): 27231 - 27236. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Nilsson, B. Skytting, Y. Xie, B. Brodin, R. Perfekt, N. Mandahl, J. Lundeberg, M. Uhlen, and O. Larsson The SYT-SSX1 Variant of Synovial Sarcoma Is Associated with a High Rate of Tumor Cell Proliferation and Poor Clinical Outcome Cancer Res., July 1, 1999; 59(13): 3180 - 3184. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawai, J. Woodruff, J. H. Healey, M. F. Brennan, C. R. Antonescu, and M. Ladanyi SYT-SSX Gene Fusion as a Determinant of Morphology and Prognosis in Synovial Sarcoma N. Engl. J. Med., January 15, 1998; 338(3): 153 - 160. [Abstract] [Full Text] [PDF] |
||||











